Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deakin

Showing results (211-220 of 1,474) with videos related to

Pageof 148
Sort By:
Journal of Theoretical Biology|November 1, 1974
A generalized model of inversion polymorphismM A Deakin, R B Teague
Entropy (Basel, Switzerland)|August 29, 2024
Support for the Time-Varying Drift Rate Model of Perceptual Discrimination in Dynamic and Static Noise Using Bayesian Model-Fitting MethodologyJordan Deakin, Andrew Schofield, Dietmar Heinke
Neuroreport|October 6, 2001
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychosesA J Law, J F Deakin
Lancet (London, England)|October 22, 2002
Uptake of flexible sigmoidoscopy screeningMike Deakin, Emma Joynes, Kathryn Millard
Journal of Psychopharmacology (Oxford, England)|January 5, 2002
Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome studyS M Dursun, J F Deakin
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
5-HT and mechanisms of defence. Author's responseJ F Deakin, F G Graeff
Molecular Biology of the Cell|December 15, 2010
Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasisNicholas O Deakin, Christopher E Turner
Neuroscience Letters|July 17, 2009
Periaqueductal grey lesions reduce morphine analgesia in the ratJ O Dostrovsky, J F Deakin
Nature|May 22, 1980
Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviourA R Green, J F Deakin
British Journal of Pharmacology|March 1, 1977
Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings]T J Crow, J F Deakin
Pageof 148

Showing results (211-220 of 1,474) with videos related to

Sort By:
Pageof 148
Journal of Theoretical Biology|November 1, 1974
A generalized model of inversion polymorphismM A Deakin, R B Teague
Entropy (Basel, Switzerland)|August 29, 2024
Support for the Time-Varying Drift Rate Model of Perceptual Discrimination in Dynamic and Static Noise Using Bayesian Model-Fitting MethodologyJordan Deakin, Andrew Schofield, Dietmar Heinke
Neuroreport|October 6, 2001
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychosesA J Law, J F Deakin
Lancet (London, England)|October 22, 2002
Uptake of flexible sigmoidoscopy screeningMike Deakin, Emma Joynes, Kathryn Millard
Journal of Psychopharmacology (Oxford, England)|January 5, 2002
Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome studyS M Dursun, J F Deakin
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
5-HT and mechanisms of defence. Author's responseJ F Deakin, F G Graeff
Molecular Biology of the Cell|December 15, 2010
Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasisNicholas O Deakin, Christopher E Turner
Neuroscience Letters|July 17, 2009
Periaqueductal grey lesions reduce morphine analgesia in the ratJ O Dostrovsky, J F Deakin
Nature|May 22, 1980
Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviourA R Green, J F Deakin
British Journal of Pharmacology|March 1, 1977
Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings]T J Crow, J F Deakin
Pageof 148